AU1812997A - Neural differentiation inducer - Google Patents
Neural differentiation inducerInfo
- Publication number
- AU1812997A AU1812997A AU18129/97A AU1812997A AU1812997A AU 1812997 A AU1812997 A AU 1812997A AU 18129/97 A AU18129/97 A AU 18129/97A AU 1812997 A AU1812997 A AU 1812997A AU 1812997 A AU1812997 A AU 1812997A
- Authority
- AU
- Australia
- Prior art keywords
- neural differentiation
- differentiation inducer
- inducer
- neural
- differentiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000004069 differentiation Effects 0.000 title 1
- 239000000411 inducer Substances 0.000 title 1
- 230000001537 neural effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8-45261 | 1996-03-04 | ||
| JP4526196 | 1996-03-04 | ||
| PCT/JP1997/000628 WO1997032579A1 (fr) | 1996-03-04 | 1997-03-03 | Agent induisant la differenciation neuronale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1812997A true AU1812997A (en) | 1997-09-22 |
Family
ID=12714356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU18129/97A Abandoned AU1812997A (en) | 1996-03-04 | 1997-03-03 | Neural differentiation inducer |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1812997A (fr) |
| WO (1) | WO1997032579A1 (fr) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3805758A1 (de) * | 1988-02-24 | 1989-09-07 | Basf Ag | Kondensierte heterocyclische verbindungen und deren verwendung |
| JPH02247166A (ja) * | 1989-03-17 | 1990-10-02 | Taisho Pharmaceut Co Ltd | ３―ピロリン―２―オン誘導体 |
| JPH0317057A (ja) * | 1989-06-15 | 1991-01-25 | Fujisawa Pharmaceut Co Ltd | 新規５員環複素環化合物 |
-
1997
- 1997-03-03 WO PCT/JP1997/000628 patent/WO1997032579A1/fr active Application Filing
- 1997-03-03 AU AU18129/97A patent/AU1812997A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997032579A1 (fr) | 1997-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3331995A (en) | Multichromic polymers | |
| AU1797799A (en) | Impedance-heated furnace | |
| AU1943495A (en) | Neuron promoter and uses | |
| AU3459897A (en) | Differentiation inhibitor | |
| AU2668195A (en) | Continuous furnace | |
| AU6245196A (en) | Serving trolley | |
| AU3994095A (en) | Thrombocytotic factor | |
| AU2549697A (en) | Epidermal differentiation factor | |
| AU3860995A (en) | Adjusting means | |
| AU2532895A (en) | Sensor | |
| AU1754095A (en) | Calender | |
| AU1812997A (en) | Neural differentiation inducer | |
| AUPN728495A0 (en) | Drier | |
| AU7715896A (en) | Inductive component | |
| AU3733095A (en) | Cytostatin ii | |
| AU3578595A (en) | Quinazoline derivative | |
| AU2610095A (en) | Sensor | |
| AU4339796A (en) | Trolley | |
| AUPM938594A0 (en) | Smokehood 173 | |
| AU2420295A (en) | Neuron differentiation accelerator | |
| AU4946697A (en) | Dihydrobenzoanthracenone, -pyrimidinone or dihydronaphtoquinolinone | |
| AUPO222296A0 (en) | Drainet 2000 | |
| AUPO049096A0 (en) | Too close | |
| AUPN095195A0 (en) | Trolley | |
| AU682291B1 (en) | Sickbed |